Menu
Close
Main Sequence is a Sydney-based venture capital fund, founded in 2017, investing from pre-seed and seed through to Series A and Series B and beyond. Its recent deals span climate and energy, hardware and robotics, space and defence and AI infrastructure, and it spun out of CSIRO, Australia's national science agency, raising a $450 million third fund in 2022. Recent investments include Kinoxis Therapeutics and Avarni.
Browse the full list of Australian startup investors, or filter by stage and sector to find the right fit.
Browse the full investor database
